PEN · Penumbra, Inc.

At the special meeting held on May 6, 2026, Penumbra, Inc. stockholders voted on three proposals related to the pending merger with Boston Scientific Corporation. The merger proposal was approved with over 28.5 million votes in favor, representing a majority of the outstanding shares, satisfying a key condition to consummation. The advisory compensation proposal also passed. The adjournment proposal was rendered unnecessary due to the merger approval. The merger remains subject to other closing conditions, including antitrust clearances. The strong shareholder support indicates confidence in the transaction's strategic rationale.